Paper4087697
Studies on the pathogenesis of cisplatin-induced hypomagnesemia in rats.
Mavichak V and 5 others. Kidney Int, 1985. Cited by 66 papers, by iCite.
Cite this record
ConductScience Library. Studies on the pathogenesis of cisplatin-induced hypomagnesemia in rats. Papers, record 4087697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4087697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Magnesium | Major topic |
| Animals | |
| Bone and Bones | |
| Homeostasis | |
| Kidney | |
| Male | |
| Muscles | |
| Parathyroid Glands | |
| Rats | |
| Sodium | |
| Thyroidectomy |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35223098 | Intravenous Administration of Cisplatin with Magnesium Sulfate Supplement May Prevent Kidney Toxicity in Rats: The Role of Gender and Magnesium Sulfate Dose. | Int J Nephrol | 2022 | https://conductscience.org/library/papers/35223098 | PubMed |
| 28758697 | Renal toxicity and chemotherapy in children with cancer. | Br J Clin Pharmacol | 2017 | https://conductscience.org/library/papers/28758697 | PubMed |
| 27057522 | Effect of Oral Magnesium Oxide Supplementation on Cisplatin-Induced Hypomagnesemia in Cancer Patients: A Randomized Controlled Trial. | Iran J Public Health | 2016 | https://conductscience.org/library/papers/27057522 | PubMed |
| 25020203 | Risk factors for cisplatin-induced nephrotoxicity and potential of magnesium supplementation for renal protection. | PLoS One | 2014 | https://conductscience.org/library/papers/25020203 | PubMed |
| 24967243 | Angiotensin Type-1 Receptor Blockade May Not Protect Kidney against Cisplatin-Induced Nephrotoxicity in Rats. | ISRN Nephrol | 2014 | https://conductscience.org/library/papers/24967243 | PubMed |
| 24959540 | Vitamin e is a nephroprotectant agent in male but not in female in a model of Cisplatin-induced nephrotoxicity. | ISRN Nephrol | 2013 | https://conductscience.org/library/papers/24959540 | PubMed |
| 24350087 | Effect of oral administration of magnesium on Cisplatin-induced nephrotoxicity in normal and streptozocin-induced diabetic rats. | Nephrourol Mon | 2013 | https://conductscience.org/library/papers/24350087 | PubMed |
| 23457647 | The TRPM6/EGF pathway is downregulated in a rat model of cisplatin nephrotoxicity. | PLoS One | 2013 | https://conductscience.org/library/papers/23457647 | PubMed |
| 23056943 | Vitamin E, Vitamin C, or Losartan Is Not Nephroprotectant against Cisplatin-Induced Nephrotoxicity in Presence of Estrogen in Ovariectomized Rat Model. | Int J Nephrol | 2012 | https://conductscience.org/library/papers/23056943 | PubMed |
| 23024853 | The Role of Magnesium Supplementation in Cisplatin-induced Nephrotoxicity in a Rat Model: No Nephroprotectant Effect. | Int J Prev Med | 2012 | https://conductscience.org/library/papers/23024853 | PubMed |
| 22563510 | Evaluation of nephroprotective and immunomodulatory activities of antioxidants in combination with cisplatin against murine visceral leishmaniasis. | PLoS Negl Trop Dis | 2012 | https://conductscience.org/library/papers/22563510 | PubMed |
| 19710391 | Chemotherapy-induced kaolin intake is increased by lesion of the lateral parabrachial nucleus of the rat. | Am J Physiol Regul Integr Comp Physiol | 2009 | https://conductscience.org/library/papers/19710391 | PubMed |
| 19629622 | Enhanced renal accumulation of cisplatin via renal organic cation transporter deteriorates acute kidney injury in hypomagnesemic rats. | Clin Exp Nephrol | 2009 | https://conductscience.org/library/papers/19629622 | PubMed |
| 16119971 | Drug-induced hypomagnesaemia : scope and management. | Drug Saf | 2005 | https://conductscience.org/library/papers/16119971 | PubMed |
| 14583761 | Severe intracellular magnesium and potassium depletion in patients after treatment with cisplatin. | Br J Cancer | 2003 | https://conductscience.org/library/papers/14583761 | PubMed |
| 8980410 | Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8980410 | PubMed |
| 7819017 | Proceedings of the American Society of Pediatric Nephrology 1993 Education Symposium, Washington, D.C., 4 May, 1993. | Pediatr Nephrol | 1994 | https://conductscience.org/library/papers/7819017 | PubMed |
| 3627965 | Influence of chronic dietary acid on renal tubular handling of magnesium. | Pflugers Arch | 1987 | https://conductscience.org/library/papers/3627965 | PubMed |
| 2813042 | Acute cisplatin nephrotoxicity in the rat. Evidence for impaired entry of sodium into proximal tubule cells. | Pflugers Arch | 1989 | https://conductscience.org/library/papers/2813042 | PubMed |
| 2686850 | Cisplatin nephrotoxicity. A review. | Cancer Chemother Pharmacol | 1989 | https://conductscience.org/library/papers/2686850 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4087697
GET https://conductscience.org/api/papers/v1/4087697/authors